Clinical Trials PSA No longer Responds to Androgen Deprivation Treatment (CRPC)
This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.
Study of a Monoclonal Antibody and Ketoconazole in Patients with Prostate Cancer
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Number: NCT02663908 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: 3 Sponsor(s): Ferring Pharmaceuticals|Memorial Sloan Kettering Cancer Center|Duke Clinical Research Institute Sponsor Trial Information Trial Location(s) and Contact(s)
Clinical Study of change in brain structure or activity in men treated with androgen receptor therapies such as abiraterone acetate and enzalutamide
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma